QuoteNo:NVUS…

The University of Virginia awarded a contract to Novogene Corporation Inc. on September 3, 2026, for ribonucleic acid (RNA) sequencing and analysis services. The contract, identified as A207_PO-0476572, has a cumulative value of $5,467.20 and encompasses a single line item for RNA library preparation and sequencing analysis. The deliverable includes NovaSeq X Plus Series sequencing (PE150 configuration) with six gigabytes of raw data per sample, access to the NovoMagic Platform for standard analysis, and RNA sample quality control services. The work is to be delivered to Carolyn Sue Smith at the University of Virginia in Virginia.

The scope of services represents a specialized genomic analysis engagement typical of higher education research support. The contract structure, with a unit price of $5,467.20 for one sequencing engagement, suggests this is a discrete analytical project rather than an ongoing service arrangement. As a prime contract awarded by a Virginia-based public institution, this engagement falls within the Commonwealth of Virginia's procurement activities and reflects the University of Virginia's utilization of external genomic sequencing capabilities to support its research operations.